Evaluation of platelet-rich plasma injection activity in the treatment of abnormal uterine bleeding

• Published in: Turkish journal of obstetrics and gynecology 2018-12, Vol.15 (4), p.222-226
• Main Authors: Turan, Gökçe, Yalçın Bahat, Pınar, Aydın, Alev, Yüksel Özgör, Bahar
• Format: Article
• Language: English
• Subjects: Blood; Blood platelets; Clinical Investigation; Gene expression; Growth factors; Gynecology; Health sciences; Hospitals; Hysterectomy; In vitro fertilization; Infertility; Kadın Hastalıkları; Menstruation; Obstetrics; Stem cells; Studies; Surgery; Tıp; Ultrasonic imaging; Wound healing
• ISSN: 2149-9322; 2149-9330
• DOI: 10.4274/tjod.93709

To evaluate the effectiveness of intracavitary platelet-rich plasma (PRP) therapy in patients diagnosed as having abnormal uterine bleeding (AUB). A total of 149 patients with AUB were included in the study. Seventy-four of these patients were included in the study group and 75 were included in the control group. All patients were evaluated using transvaginal ultrasonography. Endometrial curettage was performed to exclude underlying organic pathologies. The study group underwent intracavitary PRP therapy. Both patient groups were called for follow-up at the end of the third month. Their endometrial thickness and amount of bleeding (pictogram and pads/day) were evaluated using transvaginal ultrasonography. There was no statistically significant difference between the study and control groups in terms of the decrease in the amount of bleeding. In addition, there was no statistically significant difference between the two groups in terms of the increase in endometrial thickness. In this study, it was observed that intracavitary PRP therapy did not make a significant difference in the decrease in the amount of bleeding and in the increase in endometrial thickness between the study and control groups.